David Jorden - Nov 9, 2022 Form 4 Insider Report for Nuo Therapeutics, Inc. (AURX)

Role
CEO/CFO, Director
Signature
/s/ David Jorden
Stock symbol
AURX
Transactions as of
Nov 9, 2022
Transactions value $
-$243,750
Form type
4
Date filed
11/14/2022, 05:43 PM
Previous filing
May 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AURX Common Stock Sale -$45K -30K -1.4% $1.50 2.11M Nov 9, 2022 Direct F1
transaction AURX Common Stock Sale -$45K -30K -1.42% $1.50 2.08M Nov 9, 2022 Direct F1
transaction AURX Common Stock Sale -$40.5K -27K -1.3% $1.50 2.05M Nov 9, 2022 Direct F1
transaction AURX Common Stock Sale -$30K -20K -0.98% $1.50 2.03M Nov 9, 2022 Direct F1
transaction AURX Common Stock Sale -$30K -20K -0.98% $1.50 2.01M Nov 9, 2022 Direct F1
transaction AURX Common Stock Sale -$20.3K -13.5K -0.67% $1.50 2M Nov 9, 2022 Direct F1
transaction AURX Common Stock Sale -$15K -10K -0.5% $1.50 1.99M Nov 9, 2022 Direct F1
transaction AURX Common Stock Sale -$10.5K -7K -0.35% $1.50 1.98M Nov 9, 2022 Direct F1
transaction AURX Common Stock Sale -$7.5K -5K -0.25% $1.50 1.98M Nov 9, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported herein were made in private transactions to various persons whereby the shares of common stock acquired constitute "restricted" securities within the meaning of the Securities Act of 1933, as amended.